In addition, intestinal microbiota transplant from lean donors enhanced insulin sensitivity in individuals with metabolic syndromes [45], and that a clinical trial suggested that fecal microbiota transplantation has facilitating effects on recipient insulin sensitivity, energy expenditure and intestinal transit time [46]. This evidence concerns the gene INS and metabolic syndrome.